Projects per year
Fingerprint
Dive into the research topics where Vijayalakshmi Shridhar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Next Generation TOP1 Inhibition for the Treatment of Uterine Serous Carcinoma
Kaufmann, S. H. (PI), Bell, D. (CoPI), Bible, K. C. (CoPI), Cliby, W. A. (CoPI), Couch, F. F. J. (CoPI), Fields, A. P. (CoPI), Galanis, E. (CoPI), Goode, E. L. (CoPI), Haluska, P. R. J. (CoPI), Hartmann, L. C. (CoPI), Karnitz, L. M. (CoPI), Keeney, G. (CoPI), Knutson, K. L. (CoPI), Lengyel, E. (CoPI), Lingle, W. L. (CoPI), Long, H. (CoPI), Sherman, M. M. E. (CoPI), Moriarity, B. S. (CoPI), Block, M. S. (CoPI), Oberg, A. L. (CoPI), Peng, K.-W. (CoPI), Shridhar, V. (CoPI) & Weroha, S. (CoPI)
9/1/09 → 8/31/25
Project: Research project
-
PG545 synergizes with PARP inhibitors in ovarian cancer to disrupt DNA repair through modulation of DEK-RAD51 axis
Shridhar, V. (PI)
2/1/22 → 1/31/24
Project: Research project
-
Flavopiridol Reverses Platinum Resistance in Ovarian Cancer
Bible, K. C. (PI) & Shridhar, V. (CoPI)
7/1/09 → 8/31/14
Project: Research project
-
Regulation of Serine Protease HtrA1 and Chemoresponse
Chien, J. (CoPI) & Shridhar, V. (CoPI)
4/1/08 → 1/31/14
Project: Research project
-
Role of HSulf-1 Loss in Apoptosis and Drug Resistance
Shridhar, V. (PI)
3/1/04 → 2/28/09
Project: Research project
-
Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance
Bhowmick, S., Banerjee, S., Shridhar, V. & Mondal, S., Dec 2025, In: Molecular cancer. 24, 1, 161.Research output: Contribution to journal › Review article › peer-review
Open Access -
Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma (Oncogene, (2022), 41, 33, (4003-4017), 10.1038/s41388-022-02391-x)
Thirusangu, P., Ray, U., Sarkar Bhattacharya, S., Oien, D. B., Jin, L., Staub, J., Kannan, N., Molina, J. R. & Shridhar, V., Jan 3 2023, In: Oncogene. 42, 1, p. 79-82 4 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Detection of endometrial cancer using tampon-based collection and methylated DNA markers
Bakkum-Gamez, J. N., Sherman, M. E., Slettedahl, S. W., Mahoney, D. W., Lemens, M. A., Laughlin-Tommaso, S. K., Hopkins, M. R., VanOosten, A., Shridhar, V., Staub, J. K., Cao, X., Foote, P. H., Clarke, M. A., Burger, K. N., Berger, C. K., O'Connell, M. C., Doering, K. A., Podratz, K. C., DeStephano, C. C. & Schoolmeester, J. K. & 4 others, , Jul 2023, In: Gynecologic oncology. 174, p. 11-20 10 p.Research output: Contribution to journal › Article › peer-review
-
One more step toward treatment of PARP inhibitor-resistant ovarian cancers
Ray, U., Thirusangu, P. & Shridhar, V., 2023, In: Oncotarget. 14, p. 1034-1035 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
Ray, U., Thirusangu, P., Jin, L., Xiao, Y., Pathoulas, C. L., Staub, J., Erskine, C. L., Dredge, K., Hammond, E., Block, M. S., Kaufmann, S. H., Bakkum-Gamez, J. N. & Shridhar, V., Sep 8 2023, In: Oncogene. 42, 37, p. 2725-2736 12 p.Research output: Contribution to journal › Article › peer-review
Open Access